Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

Tigers had a skin condition causing hair loss and inflammation, but the cause is unknown and treatment didn't work.

Tofacitinib may help regrow hair in alopecia areata patients.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Tongue cancer cells show more plectin-1 than non-cancer cells, but both have similar levels of trichohyalin.

Tsukushi helps control inflammation and aids in wound healing.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Immune cells are essential for skin regeneration using biomaterial scaffolds.

Exercise-induced particles can slow breast cancer growth by boosting immune response.

CMG2 and TEM8 receptors have distinct roles in skin and growth disorders, affecting collagen breakdown and growth.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Blood cells turned into stem cells can become skin cells similar to normal ones, potentially helping in skin therapies.

The research found that chickenpox virus spreads in skin through blood then to skin cells, while shingles virus moves from nerves to hair follicle areas before infecting skin cells.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

CD2 might be a new treatment target for patchy alopecia areata.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Yak hair follicles adapt to cold through specific gene regulation, enhancing cell growth.

Betamethasone activates and increases the growth of certain skin cells from hair follicles.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.